
ImmunoGal
About the study:
The ImmunoGal study, will explore the early immune responses triggered by tick bites, with a focus on α-Gal syndrome, also known as AGS, a red meat allergy linked to tick exposure. Adults who have recently been bitten by a tick will be recruited and assessed at two time points, immediately after the bite and again 4-6 weeks later.
This study aims to enhance understanding of α-Gal syndrome and contribute to improved diagnosis and prevention strategies.

What will the ImmunoGal study consist of?
- Identification of tick species involved;
- Detection of potential pathogens transmitted by ticks;
- Assessment of immediate and late immune responses in participants;
- Evaluation of allergic sensitisation following tick bites.

What happens when you contact us?

Our research team will check if you are eligible to participate.

If so, we will explain everything about the study process and if you agree, you will be invited to meet with us for an assessment.

Meet us again for another assessment 4-6 weeks later. A subgroup will be selected for a 3rd visit up to 3 months after the first visit.
Send an email
Give us a call
+352 26 970-400
Why your participation matter:
Your participation will allow researchers to generate data and answer questions like:
- When and where do ticks bite people?
- Which kind of ticks (species and developmental stage) are biting humans?
- What percentage of ticks that bite people are infected with pathogens?
This information will help a great deal because our current understanding of tick bites is quite limited. Therefore, the ImmunoGal study will collect the relevant data on a nationwide level in Luxembourg to better understand the current situation.
By participating and donating your blood for this study, you will help us determine:
- How the human immune system defends itself against ticks and tick parasites,
- How the human immune system fights transmission of tick parasites to humans,
- Why these defence mechanisms sometimes deviate into allergic reactions such as the α-Gal syndrome.
Finding the answers to these questions will improve tick bite prevention and help refine how we diagnose and treat tick-borne diseases.

CONTACT US:
If you’re interested in contributing to this study, please reach out using the contact information below:
☎️ Call us +352 26970-400
📧 Email us at immunogal@lih.lu
Any scientific questions related to the study can be directed to our research team. For more information, please visit the webpage below:
Research Team: Molecular and Translational Allergology



